Qsymia, Belviq Approved for Obesity, Weight Loss

If you抮e obese and are at the end of your ropes looking for weight loss help, there抯 good news from the U.S. Food and Drug Administration (FDA).

The FDA in the past few months has approved two new weight loss drugs for people who struggle with obesity and being overweight ?Qsymia and Belviq.

Both Qsymia (pronounced kyoo-sim-EE-uh and manufactured by Vivus Pharmaceuticals) and Belviq (pronounced bel-VEEK and manufactured by Arena Pharmaceuticals) have been shown to be effective in their clinical trials to help people lose significant amounts of weight.

Qsymia is composed of two generic drugs, phentermine (an appetite suppressant) and topiramate (a seizure and migraine medication). Belviq focuses on changing on how serotonin is processed by the brain. Qysmia will be on sale by the end of the year, while Belviq won抰 be available until sometime in early-to-mid 2013.

GM Diet

Should you consider these drugs if you抮e obese or seriously overweight?

Negative Calorie

The short answer is, yes, if you抮e obese (BMI 30 or greater) or overweight (BMI 27 or greater) with a weight-related condition ?such as type 2 diabetes, high blood pressure, or high cholesterol ?you should consider these drugs.

Although likely to be expensive, both weight loss drugs will likely be approved by insurance companies for treatment of obesity or being overweight with other health conditions. Why? Because obesity is a serious chronic health problem affecting more than爋ne-third of U.S. adults?35.7 percent), according to the U.S. Centers for Disease Control and Prevention. As such, it costs insurers a lot of money.

1. Prev:Natural Healthy Bedtime Snacks For Weight Loss To Become Fit
2. Next:Fast Weight Loss - Watery Diet